1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Idasanutlin: new trials by email Literature Review of Idasanutlin trials Research Report on Idasanutlin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Idasanutlin With Cytarabine Versus Cytarabine Plus Placebo in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) Cytarabine, Idasanutlin, Placebo - Leukemia, Myeloid, Acute | Phase 3 | Terminated | Hoffmann-La Roche | 447 | 2015-12-30 | 2022-01-11 |
Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Finland (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Netherlands (1) · New Zealand (1) · Norway (1) · Panama (1) · Russia (1) · South Korea (1)
2014 (1)